Products
- Antibodies
- bDNA Probe Sets
- Custom Products
- Hepatocytes
- Kits
- Media
- P450 Substrates and Metabolites
- Recombinant Enzymes
- Subcellular Fractions
- Transporter Products
- XenoTech Promotions
Liver Alert
Sign up to receive E-mail notifications when fresh hepatocytes become available.Register now.
Order Product
Know what you want? Get started right now. Click Here.
Request a Quote
Contact one of our service professionals for a fast and reliable quote. Get started.
Calendar of Events
| Date | Event Name |
|---|---|
| Sep 4 - 8, 2010 | ISSX EU Meeting |
| Sep 13 - 17, 2010 | Land O'Lakes Drug Metabolism |
| Nov 14 - 18, 2010 | AAPS 2010 |
Human Liver Microsomes
PackagingCharacterization ProvidedProduct DetailsRelated Products
Human liver microsomes are used to evaluate metabolic stability and in vitro intrinsic clearance [Vmax/Km], to identify which cytochrome P450 (CYP) or UDP-glucuronosyltransferase (UGT) enzyme or enzymes are responsible for oxidizing or glucuronidating a drug candidate (a process known as reaction pheotyping or enzyme mapping), and to evaluate drug candidates as inhibitors of CYP and UGT enzymes.
Human liver microsomes contain cytochromes P450, flavin-monooxygenases, carboxylesterases, epoxide hydrolase, UDP-glucuronosyltransferases and other drug-metabolizing enzymes.
Liver microsomes from humans and toxicologically relevant species (mice, rats, rabbits, dogs and monkeys) are widely used to evaluate species differences and similarities in metabolite formation (metabolic profiling). Microsomes from liver and small intestine are used to examine the potential for first-pass metabolism of orally administered drugs. Microsomes from small intestine, kidney and lung are often used to evaluate the potential for extrahepatic metabolism of a drug candidate.
XTreme 200 Pool: Our 200 donor human liver microsome pool.
Download a Sample XTreme 200 Datasheet Here!
Commercial large pool comparisons under same assay conditions:
Direct comparison of datasheets between XT and BD is misleading. XenoTech performs all CYP assays under the same experimental conditions, whereas BD Biosciences optimizes conditions for different enzymes by changing buffer composition and/or ionic strength, depending on the CYP enzyme. These differences in assay conditions influence the individual CYP activities. XenoTech assayed these large pools (XTreme 200 and BD’s pool of 150) side-by-side under the same conditions, and found only slight differences in CYP activity between the two pools.
Comparison of CYP enzyme activities in XenoTech's XTreme 200 HLM and BD Biosciences' pool of 150 HLM:
Measured levels of immunoreactive CYP protein vary widely depending on the choice of standard (recombinant or purified CYP enzyme) and the specificity of the antibody, as reported by Perrett et al., 2007). Western immunoblotting is semi-quantitative at best because the concentration-response curve for the standard is not the same as that for the corresponding protein in microsomes.

Packaging
Concentration: 20 mg/mL
Suspension buffer: 250 mM sucrose
Characterization Provided
Specific content of cytochrome P450
Specific content of cytochrome b5
NADPH-cytochrome c reductase activity
CYP1A2 Phenacetin O-dealkylation
CYP2A6 Coumarin 7-hydroxylation
CYP2B6 Bupropion hydroxylation
CYP2C8 Amodiaquine N-dealkylation
CYP2C9 Diclofenac 4´-hydroxylation
CYP2C19 S-Mephenytoin 4´-hydroxylation
CYP2D6 Dextromethorphan O-demethylation
CYP2E1 Chlorzoxazone 6-hydroxylation
CYP3A4/5 Testosterone 6β-hydroxylation
CYP3A4/5 Midazolam 1´-hydroxylation
FMO Benzydamine N-oxygenation
UGT1A1 17β-estradiol 3-glucuronidation
UGT2B7 Morphine 3-glucuronidation
UGT1A6 1-Naphthyl glucuronidation
UGT1A9 Propofol glucuronidation
UGT1A4 Trifluoperazine glucuronidation
Donor information (age, ethnicity, gender, cause of death and infectious disease status)
Product Details
- XTreme 200 Pooled Human Liver Microsomes:
- 100 male, 100 female
- Km, Vmax and intrinsic clearance provided for each CYP
- CYP activities determined with validated LC-MS/MS methods under uniform conditions
- Study Manager, Study Director and QC review of data
- S9 fraction and cytosol available from same donor pool
- Large lots with reserve tissue from all 200 donors allow long-term availability
- Pooled Human Liver Microsomes
- At least 50 donors
- Pooled irrespective of gender or racial background
- Each sample significantly (but not necessarily equally) represented in the pool
- Offered in bulk amounts
- 5 mL at 20 mg/mL
- 50 mL at 20 mg/mL
- 81 vial box, each vial 0.5mL @ 20mg/mL
- Intended Use
- Primarily for high-throughput screening of metabolic stability of drug candidates
- Enzyme inhibition studies
- Chemical and antibody inhibition experiments
- Studies of species differences in drug metabolism
- Donor information included with each order
- Pooled Male Human Liver Microsomes
- At least 10 male donors
- Each donor equally represented in the pool
- Intended for in vitro studies of gender differences in drug metabolism
- Pooled Female Human Liver Microsomes
- At least 10 female donors
- Each donor equally represented in the pool
- Intended for in vitro studies of gender differences in drug metabolism
- CMV-Free Pooled Human Liver Microsomes
- At least eight cytomegalovirus (CMV)-negative donors
- Pooled irrespective of gender or racial background
- Each sample significantly (but not necessarily equally) represented in the pool
- Primarily for high-throughput screening of metabolic stability of drug candidates
Related Products
- Individual Human Liver Microsome samples
- Available upon request
- Contact us for information
- Genotyped Human Liver Microsomes
Caution
In the case of human tissue, XenoTech accepts only non-transplantable tissue from donors who test negative for HIV 1 and 2, HTLV, and Hepatitis B and C. However, as a precaution, all human-derived samples should be regarded as a potential biohazard and should be stored, handled and discarded accordingly. Cellular and subcellular fractions are intended for in vitro use only.
Products
| Product # | Name | Gender | Amount |
| H0604 | CMV-Free Pooled Human Liver Microsomes | Mixed | 0.5 mL at 20 mg/mL |
| H0610 | Pooled Human Liver Microsomes | Mixed | 0.5 mL at 20 mg/mL |
| H0610-81 | Pooled Human Liver Microsomes- Box of 81 | Mixed | 81, 0.5mL vials @ 20.mg/mL |
| H0620 | Pooled Human Liver Microsomes | Mixed | 1.0 mL at 20 mg/mL |
| H0630 | Pooled Human Liver Microsomes | Mixed | 5.0 mL at 20 mg/mL |
| H0640 | Pooled Human Liver Microsomes | Mixed | 50 mL at 20 mg/mL |
| H1000 | Pooled Human Liver Microsomes | Male | 0.5 mL at 20 mg/mL |
| H1500 | Pooled Human Liver Microsomes | Female | 0.5 mL at 20 mg/mL |
| H2610 | XTreme 200 Pooled Human Liver Microsomes | Mixed | 0.5 mL at 20 mg/mL |
| H2610-81 | XTreme 200 Pooled Human Liver Microsomes-Box of 81 | Mixed | 81, 0.5mL vials @ 20mg/mL |
| H2620 | XTreme 200 Pooled Human Liver Microsomes | Mixed | 1.0 mL at 20 mg/mL |
| H2630 | XTreme 200 Pooled Human Liver Microsomes | Mixed | 5.0 mL at 20 mg/mL |
| H2640 | XTreme 200 Pooled Human Liver Microsomes | Mixed | 50 mL at 20 mg/mL |

